MP9-85391-81617
3 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 665 / KS
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Moderna
-
2021-03-27
Registered in v-safe
- 2021-03-27
- 2021-03-29
-
2021-04-23
Dose 2 — Moderna
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-27
-
2021-12-17
Dose 3 — Moderna
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-12-23
Survey response — days 1–6 daily, dose 3MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Survey response — day 7, dose 3MedDRA: Cough — Feeling: Fair · HeadacheFree text: CoughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Moderna | |
| 2 | 2021-04-23 | Moderna | |
| 3 | 2021-12-17 | Moderna | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Cough
Release 10 — day 7, dose 3
Systemic reaction (other): Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release